deltatrials
Completed INTERVENTIONAL NCT06141668

Optimal Stimulation Parameters to Disrupt Epileptiform Activity

Optimal Stimulation Parameters for Spike-ripple Disruption in Patients Undergoing Invasive Monitoring

Sponsor: Boston University

Interventions Neurostimulation
Updated 5 times since 2023 Last updated: Apr 26, 2026 Started: Jun 13, 2023 Primary completion: Jun 30, 2025 Completion: Jun 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06141668, this observational or N/A phase trial focuses on Refractory Epilepsy and remains completed. Sponsored by Boston University, it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotRecruiting~Dec 2024 – ~May 2026 · 17 months · monthly snapshotRecruitingMay 4, 2026 – present · 2 months · daily API

Change History

5 versions recorded
  1. May 4, 2026 — Present [daily]

    Completed

    Status: RecruitingCompleted · Phase: NANone

  2. Dec 2024 — May 2026 [monthly]

    Recruiting NA

  3. Sep 2024 — Dec 2024 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Dec 2023 — Jul 2024 [monthly]

    Recruiting NA

    First recorded

Jun 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

Open-loop electrical stimulation has been found to reduce spike activity and seizures, but determining the optimal parameters to achieve these effects requires a brute force trial-and-error approach that relies on subjective physician discretion. We will compare the performance of stimulation parameters identified in rodent models to the recommended parameters for neuromodulation used in clinical practice.

Contact Information

Sponsor contact:
  • Boston University
  • Massachusetts General Hospital
  • National Institute of Neurological Disorders and Stroke (NINDS)
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations